Pharming Group NV (PHAR) News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Pharming Group to participate in September investor conferences

Pharming Group to participate in September investor conferences PR Newswire LEIDEN, The Netherlands, Aug. 24...

Pharming Group to convene Extraordinary General Meeting of Shareholders

Pharming Group to convene Extraordinary General Meeting of Shareholders PR Newswire LEIDEN, The Netherlands...

Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan

Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Pharming Group reports second quarter and first half 2023 financial results

Pharming Group reports second quarter and first half 2023 financial results PR Newswire LEIDEN, Netherlands...

Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board

Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board PR Newswire LEIDEN, The...

Pharming Group to report second quarter and first half 2023 financial results on August 3

Pharming Group to report second quarter and first half 2023 financial results on August 3 PR Newswire LEIDEN...